Rifaximin for severe alcoholic hepatitis-Attractive but unfructuous
- PMID: 35567764
- DOI: 10.1111/liv.15294
Rifaximin for severe alcoholic hepatitis-Attractive but unfructuous
Comment in
-
Value of pilot studies in alcohol-associated hepatitis.Liver Int. 2022 Jul;42(7):1697. doi: 10.1111/liv.15291. Epub 2022 May 23. Liver Int. 2022. PMID: 35567756 No abstract available.
Comment on
-
Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH).Liver Int. 2022 May;42(5):1109-1120. doi: 10.1111/liv.15207. Epub 2022 Mar 7. Liver Int. 2022. PMID: 35220659 Free PMC article.
References
REFERENCES
-
- Jiménez C, Ventura-Cots M, Sala M, et al. Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: a pilot study (RIFA-AH). Liver Int. 2022. doi:10.1111/liv.15207
-
- Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71:306-333.
-
- Kim HY. Statistical notes for clinical researchers: Chi-squared test and Fisher's exact test. Restor Dent Endod. 2017;42(2):152-155.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
